Alphatec Holdings, Inc. Names Leading Biomechanics Executive Andrew Mahar as Senior Director of Biomechanics and Clinical Research

CARLSBAD, Calif., Jan. 15, 2008 (PRIME NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), a leading medical technology company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders, announced today that veteran biomechanics and clinical research practitioner, Andrew Mahar, has joined the company as Senior Director of Biomechanics and Clinical Research. Andrew’s substantial product development and clinical research experience will be relied upon during the commercialization of Alphatec’s significant product pipeline.

MORE ON THIS TOPIC